Robert G. Petit
Directeur Technique/Scientifique/R&D chez OS Therapies, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Nikolai Kley | M | - |
Orionis Biosciences, Inc.
 Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 9 ans |
| Paul Romness | M | 57 |
OS Therapies, Inc.
 OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 6 ans |
| Alan Musso | M | 62 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 1 ans |
| Jan Tavernier | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | - |
| James N. Kyranos | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 8 ans |
| Colin Goddard | M | 64 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 ans |
| Matias de Tezanos | M | 44 |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 6 ans |
| Steve Gullans | M | 71 |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | - |
| Joacim Borg | M | 32 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 2 ans |
| Griet Vanpoucke | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 9 ans |
| Matias de Tezanos | M | - |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 6 ans |
| Theodore F. Search | M | 42 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 ans |
| John Ciccio | M | 43 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 ans |
| Tim Power | M | - | 18 ans | |
| William Perhacs | M | - | 17 ans | |
| Jack Doll | M | - |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| James Cornelius | M | 81 | 10 ans | |
| Peter R. Dolan | M | 68 | 18 ans | |
| Togo Dennis West | M | 81 | 10 ans | |
| John Tsai | M | 57 | 11 ans | |
| Vicki Sato | M | 75 | 15 ans | |
| Gerald Bruce | M | 68 | 8 ans | |
| Louis Gerstner | M | - | - | |
| Alan J. Lacy | M | 70 | 12 ans | |
| Michael Grobstein | M | 81 | 13 ans | |
| David J. Helfgott | M | - | - | |
| James Robinson | M | 88 | 29 ans | |
| Carl Decicco | M | 62 | 10 ans | |
| Louis J. Freeh | M | 74 | 8 ans | |
| Robert Williams | M | 75 | 7 ans | |
| Douglas Manion | M | 64 | 11 ans | |
| Douglas Hay | M | - | 6 ans | |
| Jon Wigginton | M | 62 | 5 ans | |
| Elizabeth Yamashita | F | - | 6 ans | |
| Christopher Bowden | M | 63 | 3 ans | |
| Annalisa Jenkins | M | 58 | 2 ans | |
| John Golubieski | M | 59 | 16 ans | |
| James Patrick McDermott | M | - | 3 ans | |
| Sheila Gujrathi | M | 53 | 3 ans | |
| Pankaj Mohan | M | 60 | 2 ans | |
| Fu-Min Su | M | - | 6 ans | |
| Dieter Weinand | M | 63 | 9 ans | |
| Dean Hakanson | M | 72 | 1 ans | |
| Xiaolin Liu | M | - | 2 ans | |
| Lena Elisabeth Svanberg | M | 63 | 7 ans | |
| Thomas Gibbs | M | 52 | 5 ans | |
| Ramy Ibrahim | M | 49 | 6 ans | |
| Edward Berg | M | - | 2 ans | |
| Debora Barton | M | 48 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | 3 ans |
| David Wishart | M | - | 10 ans | |
| Qin Xia | F | 56 | 1 ans | |
| Yadagiri R Pendri | M | 68 | 7 ans | |
| David Cohen | M | - | 8 ans | |
| Kevin McManus | M | - | 9 ans | |
| Karen Smith | M | 56 | 5 ans | |
| David Berman | M | - | 10 ans | |
| Mary Kay Turner | F | - | 6 ans | |
| St John McGrath | M | - | 3 ans | |
| Scott Gunther | M | 57 | 4 ans | |
| Axel Hoos | M | 54 | 6 ans | |
| Ronald Cooper | M | 61 | 7 ans | |
| Michael Castagna | M | 47 | 2 ans | |
| Cheryl Capps | F | 62 | 13 ans | |
| Pablo Lapuerta | M | 60 | 1 ans | |
| Daphne Quimi | F | 58 | 2 ans | |
| Mark Prudenti | M | - | 2 ans | |
| Donald Hayden | M | 68 | 25 ans | |
| Vance D. Coffman | M | 79 | 9 ans | |
| Louis Sullivan | M | 90 | - | |
| Ellen Futter | F | 74 | 6 ans | |
| Stuart Tross | M | 57 | 8 ans | |
| Kenneth Bahrt | M | 71 | 3 ans | |
| Eleanor Ramos | M | 67 | 2 ans | |
| Richard K. Willard | M | 75 | 2 ans | |
| Lynn H. Clark | F | 66 | 8 ans | |
| Freda Lewis-Hall | M | 69 | 5 ans | |
| Geoffrey P. Gilmore | M | 58 | 11 ans | |
| Andrew Shenker | M | 69 | 5 ans | |
| John L. McGoldrick | M | 83 | 10 ans | |
| Wendy Dixon | M | 68 | 8 ans | |
| Jeremy Levin | M | 70 | 5 ans | |
| Tamar Howson | F | 75 | 6 ans | |
| Richard Colonno | M | 74 | 16 ans | |
| Robert Martell | M | 61 | 3 ans | |
| Mark Altmeyer | M | 63 | 2 ans | |
| Laurie Alsup | M | 70 | 10 ans | |
| Mark Trudeau | M | 62 | 11 ans | |
| Stephen E. Bear | M | 73 | 7 ans | |
| Matthew Ros | M | 57 | 17 ans | |
| Valerie Sharice Grant | F | - | 3 ans | |
| William Sharbaugh | M | 61 | 6 ans | |
| Andrew Bonfield | M | 61 | 5 ans | |
| Roger Theodoredis | M | 65 | 3 ans | |
| Lubor Gaal | M | 56 | 9 ans | |
| Scott McCallister | M | 62 | 1 ans | |
| Walter Kalmans | M | - | 2 ans | |
| John P. Amos | M | 57 | 2 ans | |
| Blaine Davis | M | 50 | - | |
| R. Jean-Marc Sidney Huët | M | 55 | 1 ans | |
| Quentin Roach | M | 57 | 3 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Robert G. Petit
- Réseau Personnel
